NSPH


Monday’s Market Insights: Relypsa Inc (RLYP), Seadrill Ltd (SDRL), Nanosphere, Inc. (NSPH), XenoPort, Inc. (XNPT)

Relpysa Inc (NASDAQ:RLYP) is up over 5% after positive data from its hyperkalemia treatment, Veltassa. The company released data from analyses of studies …

Monday Morning’s Market Insights: Breitburn Energy Partners LP (BBEP), Nanosphere, Inc. (NSPH), Anacor Pharmaceuticals Inc (ANAC), Trevana Inc (TRVN)

Breitburn Energy Partners LP (NASDAQ:BBEP) is plummeting 58% in pre-market trading after the company filed for Chapter 11 bankruptcy protection. The company claimed …

Stock Update (NASDAQ:NSPH): Nanosphere, Inc. Announces First Quarter Results

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the first quarter March 31, 2016.

Stock Update (NASDAQ:NSPH): Nanosphere, Inc. Announces Record Preliminary Q4 And Full Year 2015 Results

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, reported preliminary results for the fourth quarter ended December 31, 2015.

Stock Update (NASDAQ:NSPH): Nanosphere, Inc. Announces $10 Million Registered Public Offering

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced the pricing of a public offering of the company’s common …

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Announces Record Q3 2015 Results

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results for the third quarter ended September 30, …

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Presented New Clinical Data for Verigene Blood Culture Tests at ICAAC 2015

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced that new clinical data for the Verigene® Gram-Positive (BC-GP) and …

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing the practice of medicine through targeted molecular diagnostics, today announced it has received U.

Nanosphere, Inc. (NSPH) Announces Amendment to $30 Million Term Loan Facility

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, announced today that it has amended certain terms of its $30 million term …

Company Update (NASDAQ:NSPH): Nanosphere, Inc. Announces $4.4 Million at the Market Registered Direct Offering

Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced today that it has entered into a definitive agreement with a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts